Abstract: Asa novel calcium-binding transcription repressor,also known as KChIP3/calsenilin,downstream regulatory element
antagonist modulator (DREAM)attracts much attention in recent years. In light of the latest studies concerning the effective structure
and pleiotropic function of DREAM,this review provides an introduction on both the Ca2+-sensitive and the Ca2+-independent transcription regulating movements of DREAM in pain signaling.
|